India to Switzerland: Olaparib Export Trade Route

The India to Switzerland Olaparib corridor is one of India's established pharmaceutical export routes, with 14 shipments documented worth a combined $78.2K USD. The route is dominated by VAMA HEALTH WORLD LLP, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's olaparib manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $5.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with olaparib's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 20.7%, placing it at rank #13 among India's top olaparib export destinations globally.

On the import side, key buyers of Indian olaparib in Switzerland include AS PER INVOICE AS, TO, AS PER INVOICE and 1 others. AS PER INVOICE AS is the single largest importer with 9 shipments valued at $33.9K USD.

India's olaparib exports to Switzerland are driven primarily by a handful of large-scale manufacturers. VAMA HEALTH WORLD LLP with 14 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Switzerland benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VAMA HEALTH WORLD LLP — together account for 100% of total trade value on this route. The average shipment value of $5.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicine for human consumptiontabs olaparib 100 mg tabs lynparza 100 mg batch no sf244 mfg date jan 22 and harmless medicine for human consumptiontabs olaparib 100 mg tabs lynparza 100 mg batch no sb003 mfg date may 21, suggesting that buyers in Switzerland tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, AS PER INVOICE AS is the largest importer with 9 shipments worth $33.9K USD — representing 43% of all olaparib imports from India on this route.